Vera Therapeutics, Inc. - COMMON STOCK (VERA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
VERA on Nasdaq
Shares outstanding
64,326,281
Price per share
$50.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
65,067,827
Total reported value
$1,890,768,857
% of total 13F portfolios
0.01%
Share change
+801,757
Value change
+$37,111,758
Number of holders
173
Price from insider filings
$50.64
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vera Therapeutics, Inc. - COMMON STOCK (VERA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.9% $122,354,100 5,610,000 Avoro Capital Advisors LLC 31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/ 5.7% $106,551,338 3,666,598 T. Rowe Price Associates, Inc. 30 Sep 2025
Kynam Capital Management, LP 5.4% $75,734,203 3,426,887 Kynam Capital Management, LP 30 Jun 2025
Flynn James E 5.2% $75,299,151 3,348,117 Deerfield Mgmt, L.P. 06 Jun 2025

As of 30 Sep 2025, 173 institutional investors reported holding 65,067,827 shares of Vera Therapeutics, Inc. - COMMON STOCK (VERA). This represents 101% of the company’s total 64,326,281 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) together control 80% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Avoro Capital Advisors LLC 9.7% 6,210,000 -1.4% 2.3% $180,462,600
BlackRock, Inc. 6.6% 4,247,190 +2% 0% $123,423,343
Kynam Capital Management, LP 6.3% 4,027,800 +18% 8.7% $117,047,868
PRICE T ROWE ASSOCIATES INC /MD/ 5.7% 3,666,439 -18% 0.01% $106,547,000
DEERFIELD MANAGEMENT COMPANY, L.P. 5.7% 3,641,157 +8.8% 1.6% $105,812,022
VANGUARD GROUP INC 5% 3,190,653 +6.3% 0% $92,720,376
FMR LLC 4.4% 2,843,131 -2.3% 0% $82,621,388
Eversept Partners, LP 4.4% 2,807,836 +18% 6.2% $81,595,714
Sofinnova Investments, Inc. 4.3% 2,793,987 0% 5% $81,193,262
STATE STREET CORP 3.6% 2,333,583 +16% 0% $67,813,922
Integral Health Asset Management, LLC 2.6% 1,700,000 +48% 3.6% $49,402,000
CITADEL ADVISORS LLC 2.5% 1,615,338 +187% 0.04% $46,941,722
Pictet Asset Management Holding SA 2.2% 1,439,121 +86% 0.04% $41,820,856
TANG CAPITAL MANAGEMENT LLC 2.1% 1,350,000 0% 1.5% $39,231,000
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,321,575 +2.1% 0% $38,410,686
Point72 Asset Management, L.P. 2% 1,272,027 0.08% $36,965,112
Tri Locum Partners LP 1.9% 1,190,207 +188% 8% $34,587,415
Vestal Point Capital, LP 1.2% 760,000 -75% 1% $22,085,600
GOLDMAN SACHS GROUP INC 1.2% 758,566 +50% 0% $22,043,928
Woodline Partners LP 1.1% 737,578 -72% 0.1% $21,434,017
AMERICAN CENTURY COMPANIES INC 1.1% 708,423 -0.84% 0.01% $20,586,824
SCHRODER INVESTMENT MANAGEMENT GROUP 1.1% 679,992 +82% 0.02% $19,651,769
DEUTSCHE BANK AG\ 0.99% 633,820 +4.8% 0.01% $18,418,809
Rock Springs Capital Management LP 0.96% 617,396 0% 1% $17,941,528
MILLENNIUM MANAGEMENT LLC 0.93% 598,454 +173% 0.01% $17,391,073

Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 236,632 $11,983,451 -$10,685,992 $50.64 10
2025 Q3 65,067,827 $1,890,768,857 +$37,111,758 $29.06 173
2025 Q2 63,893,006 $1,505,324,602 +$17,298,223 $23.56 171
2025 Q1 62,915,975 $1,512,521,946 -$90,036,608 $24.02 176
2024 Q4 62,912,622 $2,660,465,294 +$389,856,714 $42.29 177
2024 Q3 53,519,938 $2,365,061,605 -$1,949,648 $44.20 172
2024 Q2 52,992,297 $1,917,258,041 +$58,006,632 $36.18 169
2024 Q1 51,291,881 $2,211,712,072 +$451,505,006 $43.12 156
2023 Q4 13,762 $211,660 $15.38 1
2023 Q3 39,253,298 $538,120,156 +$9,591,096 $13.71 83
2023 Q2 38,127,621 $611,912,936 +$42,587,632 $16.05 76
2023 Q1 37,354,429 $289,749,375 +$137,823,510 $7.76 69
2022 Q4 21,217,576 $410,544,727 -$8,003,012 $19.35 56
2022 Q3 21,454,846 $457,207,997 +$21,031,831 $21.31 53
2022 Q2 20,378,033 $277,439,038 +$6,508,117 $13.61 47
2022 Q1 17,394,292 $408,238,068 +$121,776,022 $23.49 48
2021 Q4 14,028,101 $374,187,000 +$10,524,126 $26.72 36
2021 Q3 14,710,729 $252,436,000 +$4,177,142 $17.35 31
2021 Q2 14,513,290 $186,104,000 +$186,103,943 $13.25 21